在化疗诱导的心脏毒性的内皮功能障碍的内皮素基标记物
Gabrielle Boutin1, Jale Yuzugulen2, Md Zahidul Islam Pranjol1
1School of Life Sciences, University of Sussex, Brighton, UK.
Journal of molecular and cellular cardiology plus
|January 13, 2025
概括
目前的心脏生物标志物缺乏化学疗法诱导的心脏毒性的早期预测价值. 本综述探讨了内皮素-1 (ET-1) 和其片段 (ELDP,CT-proET-1) 作为内皮功能障碍和心脏毒性的早期检测有前途的生物标志物.
科学领域:
- 心脏病学 心脏病学
- 在瘤学瘤学.
- 生物标志物发现发现
背景情况:
- 目前的心脏生物标志物,如热波宁和脑性尿素,在预测化疗引起的心脏毒性方面存在局限性.
- 现有的生物标志物没有提供早期预测价值,导致癌症幸存者的不可逆转的心脏损伤.
- 内皮功能障碍评估对于在血管层面早期检测心脏毒性至关重要.
研究的目的:
- 审查当前基于血液的心脏生物标志物.
- 讨论内素-1 (ET-1) 和其片段作为内功能障碍的生物标志物的潜力.
- 探索ET-1,内末类域 (ELDP) 和C端亲内末-1 (CT-proET-1) 作为化疗诱导心脏毒性的潜在预测生物标志物.
主要方法:
- 对当前心脏生物标志物的文献综述.
- 对评估心脏毒性中热素和大脑 natriuretic 的研究分析.
- 对内皮质-1 (ET-1) 和其相关 (ELDP,CT-proET-1) 进行内皮质功能障碍和心脏毒性预测的讨论.
主要成果:
- 内甲素-1 (ET-1) 和其稳定片段ELDP和CT-proET-1显示出作为敏感生物标记物的潜力.
- 与ET-1相比,ELDP和CT-proET-1具有更高的灵敏度和更长的清除率.
- 这些生物标志物可能为检测心脏毒性提供更早的预后价值.
结论:
- 内末林-1 (ET-1) 和其片段 (ELDP,CT-proET-1) 对早期检测化疗诱导的心脏毒性具有前景.
- 需要进一步的研究才能充分理解ELDP在血管收缩中的作用及其临床应用.
- 这些生物标志物可以帮助识别有风险的患者并预防慢性心脏毒性.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
56
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
56
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
132
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
132
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
96
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
96
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381


